BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11641109)

  • 1. Peripheral urocortin inhibits gastric emptying and food intake in mice: differential role of CRF receptor 2.
    Wang L; Martínez V; Rivier JE; Taché Y
    Am J Physiol Regul Integr Comp Physiol; 2001 Nov; 281(5):R1401-10. PubMed ID: 11641109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: role of CRF receptor subtypes 1 and 2.
    Martínez V; Wang L; Rivier JE; Vale W; Taché Y
    J Pharmacol Exp Ther; 2002 May; 301(2):611-7. PubMed ID: 11961064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral urocortin delays gastric emptying: role of CRF receptor 2.
    Nozu T; Martinez V; Rivier J; Taché Y
    Am J Physiol; 1999 Apr; 276(4):G867-74. PubMed ID: 10198329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human urocortin II, a new CRF-related peptide, displays selective CRF(2)-mediated action on gastric transit in rats.
    Million M; Maillot C; Saunders P; Rivier J; Vale W; Taché Y
    Am J Physiol Gastrointest Liver Physiol; 2002 Jan; 282(1):G34-40. PubMed ID: 11751155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral corticotropin-releasing factor and stress-stimulated colonic motor activity involve type 1 receptor in rats.
    Maillot C; Million M; Wei JY; Gauthier A; Taché Y
    Gastroenterology; 2000 Dec; 119(6):1569-79. PubMed ID: 11113078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urocortin 2 acts centrally to delay gastric emptying through sympathetic pathways while CRF and urocortin 1 inhibitory actions are vagal dependent in rats.
    Czimmer J; Million M; Taché Y
    Am J Physiol Gastrointest Liver Physiol; 2006 Mar; 290(3):G511-8. PubMed ID: 16223946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracisternal urocortin inhibits vagally stimulated gastric motility in rats: role of CRF(2).
    Chen CY; Million M; Adelson DW; Martínez V; Rivier J; Taché Y
    Br J Pharmacol; 2002 May; 136(2):237-47. PubMed ID: 12010772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracerebroventricular urocortin 3 counteracts central acyl ghrelin-induced hyperphagic and gastroprokinetic effects via CRF receptor 2 in rats.
    Yeh C; Ting CH; Doong ML; Chi CW; Lee SD; Chen CY
    Drug Des Devel Ther; 2016; 10():3281-3290. PubMed ID: 27757017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urocortins and cholecystokinin-8 act synergistically to increase satiation in lean but not obese mice: involvement of corticotropin-releasing factor receptor-2 pathway.
    Gourcerol G; Wang L; Wang YH; Million M; Taché Y
    Endocrinology; 2007 Dec; 148(12):6115-23. PubMed ID: 17932219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urocortin reduces food intake and gastric emptying in lean and ob/ob obese mice.
    Asakawa A; Inui A; Ueno N; Makino S; Fujino MA; Kasuga M
    Gastroenterology; 1999 Jun; 116(6):1287-92. PubMed ID: 10348810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracerebroventricularly administered urocortin inhibits gastric emptying in mice.
    Nagata T; Uemoto M; Yuzuriha H; Asakawa A; Inui A; Fujimiya M; Sakamaki R; Kasuga M; Shinfuku N
    Int J Mol Med; 2005 Jun; 15(6):1041-3. PubMed ID: 15870911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent and long-acting corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonists.
    Rivier J; Gulyas J; Kirby D; Low W; Perrin MH; Kunitake K; DiGruccio M; Vaughan J; Reubi JC; Waser B; Koerber SC; Martinez V; Wang L; Taché Y; Vale W
    J Med Chem; 2002 Oct; 45(21):4737-47. PubMed ID: 12361401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats.
    Chen CY; Inui A; Asakawa A; Fujino K; Kato I; Chen CC; Ueno N; Fujimiya M
    Gastroenterology; 2005 Jul; 129(1):8-25. PubMed ID: 16012930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central CRF, urocortins and stress increase colonic transit via CRF1 receptors while activation of CRF2 receptors delays gastric transit in mice.
    Martínez V; Wang L; Rivier J; Grigoriadis D; Taché Y
    J Physiol; 2004 Apr; 556(Pt 1):221-34. PubMed ID: 14755002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRF-1 antagonist and CRF-2 agonist decrease binge-like ethanol drinking in C57BL/6J mice independent of the HPA axis.
    Lowery EG; Spanos M; Navarro M; Lyons AM; Hodge CW; Thiele TE
    Neuropsychopharmacology; 2010 May; 35(6):1241-52. PubMed ID: 20130533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral Corticotropin Releasing Factor Signaling Inhibits Gastric Emptying: Mechanisms of Action and Role in Stress-related Gastric Alterations of Motor Function.
    Czimmer J; Tache Y
    Curr Pharm Des; 2017; 23(27):4042-4047. PubMed ID: 28245760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral activation of corticotropin-releasing factor receptor 2 inhibits food intake and alters meal structures in mice.
    Wang L; Stengel A; Goebel M; Martinez V; Gourcerol G; Rivier J; Taché Y
    Peptides; 2011 Jan; 32(1):51-9. PubMed ID: 20969907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Water-avoidance stress enhances gastric contractions in freely moving conscious rats: role of peripheral CRF receptors.
    Nozu T; Kumei S; Takakusaki K; Okumura T
    J Gastroenterol; 2014 May; 49(5):799-805. PubMed ID: 23645119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urocortins and CRF type 2 receptor isoforms expression in the rat stomach are regulated by endotoxin: role in the modulation of delayed gastric emptying.
    Yuan PQ; Wu SV; Taché Y
    Am J Physiol Gastrointest Liver Physiol; 2012 Jul; 303(1):G20-31. PubMed ID: 22517775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists.
    de Groote L; Peñalva RG; Flachskamm C; Reul JM; Linthorst AC
    J Neurochem; 2005 Jul; 94(1):45-56. PubMed ID: 15953348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.